Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
This is strictly a medication-only service
Drugmakers and pharmacists battle over who gets to make obesity drugsBy Sydney Lupkin (NPR)Nov
New data from the Institute of Grocery Distribution (IGD)s latest quarterly report show the proportion of UK adults using medications such as Wegovy and Ozempic has nearly doubled in nine months, rising from 3.1% in June 2025 to 6% in March 2026
These medications, such as liraglutide, semaglutide, and tirzepatide, have shown significant results in lowering HbA1c levels and promoting weight loss, which is particularly beneficial for patients with coexisting diabetes and obesity
US$ 24.80
US$ 28.30
US$ 29.41
US$ 23.16
US$ 27.53
US$ 24.35
US$ 29.36
US$ 21.44
